Inhibition of Dermatan Sulfate Epimerase 1 by Substituted Glucuronic Acids
Open Access
- 27 February 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (9) , 14719-14728
Abstract
Dermatan sulfate epimerase 1 (DS-epi1) is a key enzyme in the biosynthesis of the glycosaminoglycan chondroitin sulfate/dermatan sulfate, catalyzing the conversion of glucuronic acid to iduronic acid at the polymer level. Chondroitin sulfate/dermatan sulfate chains are found on at least 32 proteoglycans, many of which are implicated in human diseases and syndromes, as well as in both malignant and normal cell development. DS-epi1 therefore represents a promising target for drug development, and recent structural studies have provided insights into its active site and catalytic mechanism. Here, we report the synthesis and biological evaluation of inhibitors based on 1,4-disubstituted glucuronic acids. These compounds were synthesized from glucose through a divergent approach, yielding 19 derivatives that were tested in a functional assay. To explore the importance of the carboxylic acid moiety, we also tested the methyl ester analog and the analogous xylose derivative. The most potent compound exhibited an IC50 of 42 ± 4 μM. Molecular dynamics simulations showed a strong interaction with the active site of DS-epi1.Keywords
Funding Information
- Crafoordska Stiftelsen
- Lunds Universitet
- Hjärt-Lungfonden (20240459)
- Kungliga Fysiografiska Sällskapet i Lund
- Liam M. Kinne Foundation
This publication has 27 references indexed in Scilit:
- Essential metals in health and diseaseChemico-Biological Interactions, 2022
- Production and HPLC-Based Disaccharide Analysis of Xyloside-Primed Glycosaminoglycans2021
- Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VIJournal of Inherited Metabolic Disease, 2013
- Uronic Acids in Oligosaccharide and Glycoconjugate Synthesis2010
- The biological role and regulation of versican levels in cancerCancer and Metastasis Reviews, 2009
- Maroteaux–Lamy syndrome: Functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B geneMolecular Genetics and Metabolism, 2008
- A novel method for regioselective ring-opening reduction of 4,6-O-benzylidene hexopyranoside derivatives using CoCl2 and BH3·THFTetrahedron Letters, 2007
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyThe Journal of Pediatrics, 2006
- TEMPO-mediated oxidation of maltodextrins and d-glucose: effect of pH on the selectivity and sequestering ability of the resulting polycarboxylatesCarbohydrate Research, 2001
- Synthesis of analogs of 1,1-linked galactosyl mannoside as mimetics of sialyl Lewis X tetrasaccharideTetrahedron, 1998